Poor responders in IVF: an update in therapy

References

• Marci R, Lisi F, Soave I, et al. Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist. Gynecol Endocrinol 2012;28:792–5
   PubMed Web of Science ®Google Scholar
• Carbone MC, Tatone C, Delle Monache S, et al. Antioxidant enzymatic defenses in human follicular fluid: characterization and age-dependent changes. Mol Hum Reprod 2003;9:639–43
   PubMed Web of Science ®Google Scholar
• Tatone C, Amicarelli F, Carbone MC, et al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update 2008;14:131–42
   PubMed Web of Science ®Google Scholar
• Venetis CA, Kolibianakis EM, Tarlatzi TB, Tarlatzis BC. Evidence-based management of poor ovarian response. Ann N Y Acad Sci 2010;1205:199–206
   PubMed Web of Science ®Google Scholar
• Garcia JE, Jones GS, Acosta AA, Wright G. HMG/hCG follicular maturation for oocytes aspiration: phase II, 1981. Fertil Steril 1983;39:174–9
   PubMed Web of Science ®Google Scholar
• Loumaye E. The control of endogenous secretion of LH by gonadotropin-releasing hormone agonists during ovarian hyper- stimulation for in-vitro fertilization and embryo transfer. Hum Reprod 1990;5:357–76
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, La Marca A, Fauser BCJM, et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Kwee J, Hendriks DJ, et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685–718
   PubMed Web of Science ®Google Scholar
• McLaren JF. Infertility evaluation. Obstet Gynecol Clin North Am 2012;39:453–63
   PubMedGoogle Scholar
• Chandra A, Martinez GM, Mosher WD, et al. Fertility, family planning, and reproductive health of U.S. women: data from 2002 National Survey of Family Growth. Vital Health Stat 2005;23:1–160
   Google Scholar
• Sadow CA, Anik Sahni V. Imaging female infertility. Abdom Imaging 2014;39:92–107
   PubMedGoogle Scholar
• Marci R, Caserta D, Lisi F, et al. In vitro fertilization stimulation protocol for normal responder patients. Gynecol Endocrinol 2013;29:109–12
   PubMed Web of Science ®Google Scholar
• Marci R, Graziano A, Lo Monte G, et al. GnRH antagonists in assisted reproductive techniques: a review on the Italian experience. Eur Rev Med Pharmacol Sci 2013;17:853–73
   PubMed Web of Science ®Google Scholar
• Garcia JE, Jones GS, Acosta AA, Wright G. HMG/hCG follicular maturation for oocytes aspiration: phase II, 1981. Fertil Steril 1983;39:174–9
   PubMed Web of Science ®Google Scholar
• Su HI. Measuring ovarian function in young cancer survivors. Minerva Endocrinol 2010;35:259–70
   PubMedGoogle Scholar
• Giugliano E, Cagnazzo E, Giugliano B, et al. Can Doppler study of the ovarian artery predict the fertility outcome of intrauterine insemination? J Clin Ultrasound 2014;42:331–5
   PubMedGoogle Scholar
• Weissman A, Farhi J, Royburt M, et al. Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer. Fertil Steril 2003;79:886–892
   PubMed Web of Science ®Google Scholar
• Marci R, Caserta D, Dolo V, et al. GnRH antagonist in IVF poor-responder patients: results of a randomized trial. Reprod Biomed Online 2005;11:189–93
   PubMed Web of Science ®Google Scholar
• Pu D, Wu J, Liu J. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod 2011;26:2742–9
   PubMed Web of Science ®Google Scholar
• Malmusi S, La Marca A, Giulini S, et al. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril 2005;84:402–6
   PubMed Web of Science ®Google Scholar
• Tazegül A, Görkemli H, Özdemir S, Aktan TM. Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial. Arch Gynecol Obstet 2008;278:467–72
   PubMed Web of Science ®Google Scholar
• Kahraman K, Berker B, Atabekoglu CS. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection–embryo transfer cycle. Fertil Steril 2009;91:2437–44
   PubMed Web of Science ®Google Scholar
• Xiao J, Chang S, Chen S. The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril 2013;100:1594–601
   PubMed Web of Science ®Google Scholar
• De Placido G, Mollo A, Clarizia R, et al. Gonadotropin-releasing hormone GnRH antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response. Fertil Steril 2006;85:247–50
   PubMed Web of Science ®Google Scholar
• Morgia F, Sbracia M, Schimberni M, et al. A controlled trial of natural cycle versus microdose gonadotropin- releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 2004;81:1542–7
   PubMed Web of Science ®Google Scholar
• Wiser A, Gonen O, Ghetler Y, et al. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 2010;25:2496–500
   PubMed Web of Science ®Google Scholar
• EMKolibianakis EM, Venetis CA, Diedrich K, et al. Addition of growth hormone to gonadotropins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 2009;15:613–22
   PubMedGoogle Scholar
• Filicori MD, Cognigni GE, Gamberini E, et al. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005;84:394–401
   PubMed Web of Science ®Google Scholar
• Frattarelli JL, Peterson EH. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 2004;81:1713–14
   PubMed Web of Science ®Google Scholar
• Sunkara SK, Pundir J, Khalaf Y. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis. Reprod BioMed Online 2011;22:545–55
   PubMed Web of Science ®Google Scholar
• Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertil Steril 2007;88:665–9
   PubMed Web of Science ®Google Scholar
• Barrenetxea G, Agirregoikoa JA, Jimenez MR, et al. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546–53
   PubMedGoogle Scholar
• D’Amato G, Caroppo E, Pasquadibisceglie A, et al. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 2004;81:1572–7
   PubMed Web of Science ®Google Scholar
• Massin N, Cedrin-Durnerin I, Coussieu C, et al. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique – a prospective, randomized, double-blind study. Hum Reprod 2006;21:1204–11
   PubMedGoogle Scholar
• Fabregues F, Penarrubia J, Creus M, et al. Transdermal testosterone may improve ovarian response to gonadotropins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 2009;24:349–59
   PubMed Web of Science ®Google Scholar
• Kim C-H, Howles CM, Lee HA. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril 2011;95:679–83
   PubMed Web of Science ®Google Scholar
• Goswami SK, Das T, Chattopadhyay R, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 2004;19:2031–5
   PubMed Web of Science ®Google Scholar
• Schmidt DW, Bremner T, Orris JJ, et al. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 2005;83:1568–7
   PubMed Web of Science ®Google Scholar
• Lok IH, Yip SK, Cheung LP, et al. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril 2004;81:556–61
   PubMed Web of Science ®Google Scholar